Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov;25(7):e14076.
doi: 10.1111/petr.14076. Epub 2021 Jun 29.

Quality improvement project to improve vaccinations in the pediatric liver transplant population

Alexis J Gumm  1 , Stacee Lerret  1 , Matthew Zeman  1 , Janelle Rueter  1 , Anna R Huppler  2 , Zahida Khan  1 , Grzegorz Telega  1 , Bernadette Vitola  1
Affiliations

Quality improvement project to improve vaccinations in the pediatric liver transplant population

Alexis J Gumm et al. Pediatr Transplant. 2021 Nov.

Abstract

Objectives: A quality improvement approach was used to increase pediatric liver transplant recipient live and inactive vaccination rates by assessing titers and recommending vaccinations.

Methods: A new screening and immunization process for both live and inactive vaccines was discussed with families at their annual visit. Antibody titers for varicella, measles, mumps, rubella, Haemophilus influenzae type B, hepatitis A, and hepatitis B were obtained. Specific criteria were developed for live virus vaccination candidacy. Vaccines were recommended based on patient titers and vaccination candidacy criteria. Surveillance for adverse effects to live vaccines was performed. Repeat titers were obtained approximately 1-month post-vaccine administration.

Results: After PDSA cycle 1, 99% (71/72) of pediatric liver transplant patients had titers obtained. Live vaccines were recommended for 32 patients and 16 (50%) were vaccinated. Inactive vaccines were recommended to 64 patients, and 31 (48%) were vaccinated. Eight of 13 (62%) patients with follow-up titers achieved immunity for inactive vaccines. Zero patients had an adverse reaction to any live vaccine. Ten of 12 (83%) patients with follow-up titers achieved immunity from live vaccines. The most common barriers to receive live vaccines included not scheduling appointment with primary care provider (n = 3) and "non-vaccinators" (n = 3).

Conclusions: Administering live and inactive vaccines to select pediatric liver transplant patients appears to be safe and effective in our studied population. For PDSA cycle 2, we will continue our current practice and consider offering vaccines in transplant clinic, since this was a barrier to vaccination identified during PDSA cycle 1.

Keywords: immunizations; live vaccines; liver transplant; quality improvement.

PubMed Disclaimer

References

REFERENCES

    1. Danziger-Isakov L, Kumar D. Guidelines for vaccination of solid organ transplant candidates and recipients. Am J Transplant. 2009;9:S258-S262. https://doi.org/10.1111/j.1600-6143.2009.02917.x
    1. Brady MT, Jackson MA, Long SS, Kimberlin DW. Red Book: 2018-2021 Report of the Committee on Infectious Diseases. American Academy of Pediatrics; 2018.
    1. Clemmons NS, Wallace GS, Patel M, Gastanaduy PA. Incidence of measles in the United States. JAMA. 2017;318(13):1279-1281. https://doi.org/10.1001/jama.2017.9984
    1. Centers for Disease Control and Prevention. Measles cases and outbreaks. 2021. cdc.gov/measles/cases-outbreaks.html
    1. Mahase E. Measles cases rise 300% globally in first few months of 2019. BMJ. 2019;365:1810. https://doi.org/10.1136/bmj.l1810

LinkOut - more resources